OTC: NGENF - NervGen Pharma Corp.

Yield per half year: +1.38%
Dividend yield: 0.00%
Sector: Healthcare

Share chart NervGen Pharma Corp.

Extended chart Simple chart
Financial Markets by TradingView

About NervGen Pharma Corp.

NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. The company's lead product candidate is NVG-291 that is in phase 1 clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. It has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage.

more details
The company was incorporated in 2017 and is based in Vancouver, Canada.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nervgen.com
Цена ао 1.85
Change price per day: 0% (1.84)
Change price per week: -0.5405% (1.85)
Change price per month: -4.17% (1.92)
Change price per 3 month: -15.98% (2.19)
Change price per half year: +1.38% (1.815)
Change price per year: +14.29% (1.61)
Change price per 3 year: +9.52% (1.68)
Change price per 5 year: +30.5% (1.41)
Change price per year to date: -15.21% (2.17)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV -51.72 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % -127.69 0
ROE, % 830 10
Total: 1.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1369.23 10
Yield EPS, % -16.09 0
Total: 3.8
More



Head Job title Payment Year of birth
Mr. William Joseph Radvak BASc Co-Founder & Advisor 44.12k 1963 (62 years)
Dr. Harold Martin Punnett D.M.D. Co-Founder & Independent Director N/A
Dr. Daniel D. Mikol M.D., Ph.D. Chief Medical Officer 583.89k
Mr. Michael Kelly CEO, President & Director 544.43k 1966 (59 years)
Mr. Brian McAlister Co-Founder & Advisor N/A
Mr. William J. Adams C.A., CPA, CA, CPA CFO & Corporate Secretary 1962 (63 years)
Dr. Charles V. Olson D.Sc. Senior Vice President of Technical Operations 1957 (68 years)
Ms. Elizabeth Eberhardt B.Sc. Senior Vice President of Program Management

Address: Canada, Vancouver. BC VM X, 2955 Virtual Way - open in Google maps, open in Yandex maps
Website: https://www.nervgen.com